search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    Altimmune, Inc.

    (NASDAQ:ALT)

    $12.2

    $0.94

    8.35%

    Altimmune, Inc. Chart

    ALT Stock Price Today

    Altimmune, Inc. (ALT) stock rallied over 8.35% intraday to trade at $12.20 a share on NASDAQ. The stock opened with a gain of 4.45% at $11.22 and touched an intraday high of $12.37, rising 8.35% against the last close of $11.26. The stock went to a low of $10.9 during the session.

    Stock Snapshot

    $11.26

    Prev. Close

    547.9 Million

    Market Cap

    $10.9

    Day Low

    $11.22

    Open

    43.97 Million

    Number of Shares

    $12.37

    Day High

    -

    P/E ratio

    -2.41

    EPS (TTM)

    4.43

    Cash Flow per Share

    15.07

    Free Float in %

    5.28

    Book Value

    1,754,027

    Volume

    Altimmune, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-05$11.22$12.37$10.9$12.21,755,267
    2022-07-01$11.68$12.01$10.79$11.261,581,200
    2022-06-30$11.52$11.95$11.2$11.71,102,700
    2022-06-29$11.46$12.005$10.901$11.772,171,300
    2022-06-28$11.54$11.73$10.81$11.642,086,500
    2022-06-27$10.18$12.028$9.745$11.754,019,200
    2022-06-24$10.67$11$9.6$10.297,091,800
    2022-06-23$9.37$10.65$9.23$10.61,986,800
    2022-06-22$9.08$9.601$9.001$9.441,271,500
    2022-06-21$8.97$9.77$8.7$9.322,551,900

    Contact Details

    910 Clopper Road
    Suite 201S
    Gaithersburg, MD 20878
    United States

    Webiste:ALT

    240 654 1450

    Company Information

    Employees-

    Beta0.48

    Sales or Revenue4.41 Million

    5Y Sales Change6.40%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

    Frequently Asked Questions

    icon

    What is the current Altimmune, Inc. (ALT) stock price?

    Altimmune, Inc. (NASDAQ: ALT) stock price is $12.2 as of the last check on Tuesday, July 5. During the trading session, ALT stock reached the peak price of $12.37 while $10.9 was the lowest point it dropped to.

    icon

    ALT's industry and sector of operation?

    The NASDAQ listed ALT is part of Biotechnology industry that operates in the broader Health Care sector. Altimmune, Inc. , a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases.

    icon

    Who are the executives of ALT?

    Mr. Richard I. Eisenstadt M.B.A.
    CFO and Principal Financial & Accounting Officer
    Dr. Vipin K. Garg Ph.D.
    Pres, CEO & Director
    Mr. Richard I. Eisenstadt M.B.A.
    Chief Financial Officer
    Dr. M. Scot Roberts Ph.D.
    Chief Scientific Officer

    icon

    What is the ALT stock price today?

    ALT stock traded closed the last session at $12.2, which is $0.94 or 8.35% lower than its previous close of $11.26. ALT's current trading price is 218.54% lower than its 52-week high of $17.26 where as its distance from 52-week low of 3.83% is -29.32%.

    icon

    How many employees does ALT have?

    Number of ALT employees currently stands at -. ALT operates from 910 Clopper Road, Suite 201S, Gaithersburg, MD 20878, United States.

    icon

    Link for ALT official website?

    Official Webiste of $ALT is: https://altimmune.com

    icon

    How do I contact ALT?

    ALT could be contacted at ALT operates from 910 Clopper Road, Suite 201S, Gaithersburg, MD 20878, United States, or at phone #240 654 1450 and can also be accessed through its website.

    icon

    How many shares of ALT are traded daily?

    ALT stock volume for the day was 1,754,027 shares while in the previous session number of ALT shares traded was 1,755,267 . The average number of ALT shares traded daily for last 3 months was 1.3 Million.

    icon

    How much did ALT change today?

    The percentage change in ALT stock occurred in the recent session was 8.35% while the dollar amount for the price change in ALT stock was $0.94.

    icon

    What price range ALT stock been trading in?

    In the recent session, the day high for ALT stock was $12.37 while the low for ALT stock touched on the day was $10.9.

    icon

    What is the market cap of ALT currently?

    The market value of ALT currently stands at 547.9 Million with its latest stock price at $12.2 and 43.97 Million of its shares outstanding.